Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

BioNordic A/S Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 N/A 2019 N/A 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   0.0% 0.0% 1.2% 2.5% 2.6% 0.9% 4.2% 4.1%   Credit score (0-100)   0 0 82 61 61 87 48 49   Credit rating   N/A N/A A BBB BBB A BBB BBB   Credit limit (kDKK)   0.0 0.0 1,282.1 0.2 0.1 6,606.4 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 N/A 2019 N/A 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   0.0 0.0 58,005 40,332 77,810 95,559 0.0 0.0   EBITDA   0.0 0.0 37,224 40,332 28,588 56,930 0.0 0.0   EBIT   0.0 0.0 27,054 40,332 19,027 43,562 0.0 0.0   Pre-tax profit (PTP)   0.0 0.0 25,573.3 408.2 11,296.5 33,904.0 0.0 0.0   Net earnings   0.0 0.0 16,474.9 408.2 5,156.9 24,548.6 0.0 0.0   Pre-tax profit without non-rec. items   0.0 0.0 25,573 40,332 11,296 33,904 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 N/A 2019 N/A 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   0.0 0.0 23,654 0.0 26,526 30,924 0.0 0.0   Shareholders equity total   0.0 0.0 17,087 18,211 24,828 48,871 48,371 48,371   Interest-bearing liabilities   0.0 0.0 140,756 0.0 145,243 209,920 0.0 0.0   Balance sheet total (assets)   0.0 0.0 199,440 252,629 394,101 413,922 48,371 48,371   Net Debt   0.0 0.0 126,508 0.0 124,249 188,969 -16,434 -16,434     See the entire balance sheet 1000.0 Volume  2018 N/A 2019 N/A 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   0.0 0.0 58,005 40,332 77,810 95,559 0.0 0.0   Gross profit growth   0.0% 0.0% 0.0% -30.5% 92.9% 22.8% -100.0% 0.0%   Employees   0 0 59 0 98 83 0 0   Employee growth %   0.0% 0.0% 0.0% -100.0% 0.0% -15.3% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   0 0 199,440 252,629 394,101 413,922 48,371 48,371   Balance sheet change%   0.0% 0.0% 0.0% 26.7% 56.0% 5.0% -88.3% 0.0%   Added value   0.0 0.0 37,224.4 40,332.0 19,027.2 56,929.9 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 37,831 -48,002 52,111 -12,178 -30,924 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   0.0 0.0 1.0 2.0 3.0 4.0 0.0 0.0   1000.0 Profitability  2018 N/A 2019 N/A 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   0.0% 0.0% 46.6% 100.0% 24.5% 45.6% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   0.0% 0.0% 14.3% 17.8% 6.0% 12.1% 0.0% 0.0%   ROI %   0.0% 0.0% 16.5% 19.0% 8.9% 22.2% 0.0% 0.0%   ROE %   0.0% 0.0% 96.4% 2.3% 24.0% 66.6% 0.0% 0.0%   1000.0 Solidity  2018 N/A 2019 N/A 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   0.0% 0.0% 8.6% 100.0% 6.3% 11.8% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   0.0% 0.0% 339.9% 0.0% 434.6% 331.9% 0.0% 0.0%   Gearing %   0.0% 0.0% 823.7% 0.0% 585.0% 429.5% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 4.1% 0.0% 11.3% 8.5% 0.0% 0.0%   1000.0 Liquidity  2018 N/A 2019 N/A 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.0 0.0 1.1 0.0 0.4 0.5 0.0 0.0   Current Ratio   0.0 0.0 3.1 0.0 1.5 2.1 0.0 0.0   Cash and cash equivalent   0.0 0.0 14,248.1 0.0 20,993.8 20,951.0 0.0 0.0   1000.0 Capital use efficiency  2018 N/A 2019 N/A 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   0.0 0.0 101,243.6 0.0 112,830.5 184,846.8 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 N/A 2019 N/A 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 631 0 194 686 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 631 0 292 686 0 0   EBIT / employee   0 0 459 0 194 525 0 0   Net earnings / employee   0 0 279 0 53 296 0 0